Full text
PDF![21](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/7d6d17c52997/jcinvest00536-0027.png)
![22](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/dd6bfc02d42d/jcinvest00536-0028.png)
![23](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/612d1bdfa4f2/jcinvest00536-0029.png)
![24](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/73ec23e896c6/jcinvest00536-0030.png)
![25](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/347fe55c531e/jcinvest00536-0031.png)
![26](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/c446975bba4f/jcinvest00536-0032.png)
![27](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/d6f6819245d7/jcinvest00536-0033.png)
![28](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/01355f0c1068/jcinvest00536-0034.png)
![29](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/3509db7b6d76/jcinvest00536-0035.png)
![30](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/d3daa029e495/jcinvest00536-0036.png)
![31](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/e0e1fceef263/jcinvest00536-0037.png)
![32](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/e9f0262322e6/jcinvest00536-0038.png)
![33](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/a9d4a8fb0375/jcinvest00536-0039.png)
![34](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/1b6ac3b3e0db/jcinvest00536-0040.png)
![35](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c0/424757/23dad2ee5096/jcinvest00536-0041.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Francis T. STUDIES ON PATHOGENESIS AND RECOVERY IN ERYSIPELAS. J Clin Invest. 1928 Oct;6(2):221–236. doi: 10.1172/JCI100193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keefer C. S., Myers W. K., Oppel T. W. STREPTOCOCCAL AGGLUTININS IN PATIENTS WITH RHEUMATOID (ATROPHIC) ARTHRITIS AND ACUTE RHEUMATIC FEVER. J Clin Invest. 1933 Mar;12(2):267–277. doi: 10.1172/JCI100501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keefer C. S., Spink W. W. STUDIES OF HEMOLYTIC STREPTOCOCCAL INFECTION I. FACTORS INFLUENCING THE OUTCOME OF ERYSIPELAS. J Clin Invest. 1936 Jan;15(1):17–19. doi: 10.1172/JCI100754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Myers W. K., Keefer C. S. ANTISTREPTOLYSIN CONTENT OF THE BLOOD SERUM IN RHEUMATIC FEVER AND RHEUMATOID ARTHRITIS. J Clin Invest. 1934 Jan;13(1):155–167. doi: 10.1172/JCI100575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Myers W. K., Keefer C. S., Holmes W. F. THE RESISTANCE TO FIBRINOLYTIC ACTIVITY OF THE HEMOLYTIC STREPTOCOCCUS WITH SPECIAL REFERENCE TO PATIENTS WITH RHEUMATIC FEVER AND RHEUMATOID (ATROPHIC) ARTHRITIS. J Clin Invest. 1935 Jan;14(1):119–123. doi: 10.1172/JCI100646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Myers W. K., Keefer C. S., Oppel T. W. SKIN REACTIONS TO NUCLEOPROTEIN OF STREPTOCOCCUS SCARLATINAE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND RHEUMATIC FEVER. J Clin Invest. 1933 Mar;12(2):279–289. doi: 10.1172/JCI100502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tillett W. S., Edwards L. B., Garner R. L. FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS. J Clin Invest. 1934 Jan;13(1):47–78. doi: 10.1172/JCI100579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tillett W. S. THE OCCURRENCE OF ANTIFIBRINOLYTIC PROPERTIES IN THE BLOOD OF PATIENTS WITH ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS. J Clin Invest. 1935 Mar;14(2):276–284. doi: 10.1172/JCI100675. [DOI] [PMC free article] [PubMed] [Google Scholar]